ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Brainstorm Cell Therapeutics Inc (QB)

Brainstorm Cell Therapeutics Inc (QB) (BCLI)

1,44
0,15
(11,63%)
Fermé 04 Juillet 10:00PM

Brainstorm Cell Therapeutics Inc (QB) (BCLI) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
1,44
( 11,63% )
Prix Achat
1,16
Prix Vente
1,50
Volume échangé
122 440
1,0496 Fourchette du Jour 1,63
0,4589 Plage de 52 semaines 1,63
Cap du marché
Clôture Veille
1,29
Ouverture
1,29
Dernière Transaction
400
@
1.44
Dernière heure de transaction
Volume financier
US$ 169 200
VWAP
1,3819
Volume moyen (3 m)
US$ 11 829
Actions en circulation
11 034 775
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-1,41
Bénéfice par action (BPA)
-0,92
Chiffre d'affairess (LTM)
-
Bénéfice net (LTM)
-9,57M

À propos de Brainstorm Cell Therapeutics Inc (QB)

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company’s NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologo... Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company’s NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is involved in the development of NurOwn, which has completed Phase IIIb clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of Alzheimer’s disease, as well as for treatment of other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
New York, United States
Fondé
2026
Brainstorm Cell Therapeutics Inc (QB) est coté dans le secteur Healthcare de la OTC Markets avec le ticker BCLI. Le dernier cours de clôture d'Brainstorm Cell Therapeu... (QB) était de US$1,29. Au cours de la dernière année, les actions de Brainstorm Cell Therapeu... (QB) ont été négociées dans une fourchette de prix de US$ 0,4589 à US$ 1,63.

Brainstorm Cell Therapeu... (QB) compte actuellement 11 034 775 actions en circulation. La capitalisation boursière d'Brainstorm Cell Therapeu... (QB) est de US$15,89 million. Brainstorm Cell Therapeu... (QB) a un ratio cours/bénéfice (ratio PE) de -1.41.

BCLI Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.450545.52804446690.98951.630.9212181.13452415CS
40.647581.70347003150.79251.630.72147930.94169778CS
120.562564.10256410260.87751.630.600146119080.8206615CS
260.89161.8181818180.551.630.4589162600.72505677CS
520.74105.7142857140.71.630.4589303760.6998376CS
156-2.75-65.63245823394.194.190.4589296350.6998376CS
260-2.75-65.63245823394.194.190.4589289290.6998376CS

BCLI - Frequently Asked Questions (FAQ)

What is the current Brainstorm Cell Therapeutics Inc (QB) share price?
The current share price of Brainstorm Cell Therapeutics Inc (QB) is US$ 1,44
How many Brainstorm Cell Therapeutics Inc (QB) shares are in issue?
Brainstorm Cell Therapeutics Inc (QB) has 11 034 775 shares in issue
What is the market cap of Brainstorm Cell Therapeutics Inc (QB)?
The market capitalisation of Brainstorm Cell Therapeutics Inc (QB) is USD 15,89M
What is the 1 year trading range for Brainstorm Cell Therapeutics Inc (QB) share price?
Brainstorm Cell Therapeutics Inc (QB) has traded in the range of US$ 0,4589 to US$ 1,63 during the past year
What is the PE ratio of Brainstorm Cell Therapeutics Inc (QB)?
The price to earnings ratio of Brainstorm Cell Therapeutics Inc (QB) is -1,41
What is the registered address of Brainstorm Cell Therapeutics Inc (QB)?
The registered address for Brainstorm Cell Therapeutics Inc (QB) is 1325 Avenue of Americas, New York, New York, 10019
What is the Brainstorm Cell Therapeutics Inc (QB) website address?
The website address for Brainstorm Cell Therapeutics Inc (QB) is www.brainstorm-cell.com
Which industry sector does Brainstorm Cell Therapeutics Inc (QB) operate in?
Brainstorm Cell Therapeutics Inc (QB) operates in the Biotechnology & Life Sciences sector

BCLI Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion